LIVING WITH HIV

Menu open

UNDETECTABLE EQUALS UNTRANSMITTABLE (U=U)

UNDETECTABLE EQUALS UNTRANSMITTABLE (U=U)

'Undetectable = Untransmittable' (U=U) has transformed our understanding of HIV. Thanks to effective HIV treatment, people who maintain an undetectable viral load cannot pass on HIV through sex.1 This breakthrough has changed lives by reducing stigma, improving confidence and helping people living with HIV build healthier relationships.2–5

This page explains what U=U means, the science behind it, what it means to be undetectable, how U=U applies in different situations, the importance of conversations about U=U, and answers to frequently asked questions.

WHAT IS U=U?

U=U stands for 'Undetectable = Untransmittable'. The U=U message is simple; if people living with HIV regularly take their medications, they can reach an undetectable viral load, preventing the transmission of the virus to their HIV-negative sexual partners.1 This holds true even in scenarios where condoms are not used and partners are not using pre-exposure prophylaxis (PrEP).6,7

Talking to your doctor can help you to understand how this relates to you and your needs specifically.

WHAT IS THE MEANING OF UNDETECTABLE HIV?

Undetectable HIV occurs when an individual’s viral load (the amount of virus detected in someone’s blood) is so low that it can’t be detected through standard blood tests.8 This is usually due to effective antiretroviral therapy (ART), where a combination of medications is prescribed to manage the progression of the virus.8

People living with HIV who have an undetectable viral load and use World Health Organization (WHO)-approved testing methods, including dried blood spot samples, can take their medication as directed without risk of passing on HIV to their partners. test for HIV.9

  • How do you know if you have undetectable HIV?

    Undetectable HIV is confirmed through viral load testing, which is the gold standard for monitoring response to ART and ongoing viral suppression.10 These tests measure the amount of HIV in the blood, and an undetectable result indicates that the virus is present at levels too low to be detected by standard tests.8

  • What HIV viral load is undetectable?

    HIV viral load is categorised into three levels: undetectable, suppressed, and unsuppressed. The Centres for Disease Control and Prevention (CDC) defines an undetectable viral load as having fewer than 200 copies of HIV per millilitre of blood. This signifies effective control of the virus. The WHO acknowledges that those with an undetectable viral load who consistently take their prescribed medication have an almost zero or negligible risk of transmitting HIV to their sexual HIV-negative partners.9

  • How long does it take to become HIV undetectable?

    How long it takes to reach an undetectable HIV viral load varies and is based on factors like your CD4 count (a measure of your immune system health), medication adherence, and the chosen ART.11,12 Effective ART can lead to a rapid viral load reduction within a period of one to six months. A person is considered ‘durably undetectable’ when all viral load tests remain undetectable for at least six months after the first undetectable result. Achieving this status typically requires being on treatment for seven to twelve months.13

    Following an effective ART treatment plan as prescribed is important to reach an undetectable viral load. While U=U is a significant advancement in HIV prevention, achieving this may not be feasible for everyone due to socioeconomic factors, access to healthcare, substance use challenges, and psychological wellbeing.14–16 Advocacy, education, and increased accessibility to HIV testing and treatment are essential to ensure that the benefits of U=U extend to everyone.17–19

  • Can undetectable HIV become detectable?

    Yes, if therapy is stopped, the viral load can become detectable once again. Maintaining consistency in taking medication is essential to sustain undetectability. Being HIV undetectable differs from being HIV negative. Despite having an undetectable viral load, the virus is still present in the body.13

    Detectability can also occur due to virological failure, which is the inability to achieve or maintain viral load suppression. HIV drug resistance can be another risk, potentially leading to detectable viral loads.20

    To prevent these risks, open discussions with healthcare professionals (HCPs) about treatment and adherence are crucial. Regular communication aids in tailoring effective treatment regimens, promoting adherence, and enhancing overall quality of life.20,21

  • Can you test negative if you have undetectable HIV?

    It depends on the type of HIV test. People living with HIV who are undetectable will still test positive on HIV diagnostic tests that detect antibodies or antigens because HIV remains in the body.8,22 However, viral load tests measure the amount of HIV RNA in the blood and may report a result of "not detected" when the amount of HIV is below the test's limit of detection.22,23

CAN UNDETECTABLE HIV BE TRANSMITTED?

According to the World Health Organisation (WHO), people living with HIV who maintain an undetectable viral load through any WHO-approved test and adhere to prescribed medication have an almost zero risk of transmitting HIV to their sexual partners.9

“Learning that undetectable equals untransmittable really changed things. It means that I don’t have to worry about passing HIV on through sex, or to my baby” –Mercy (born with HIV)

  • What does ‘untransmittable HIV’ mean?

    ‘Untransmittable HIV’ means that the virus cannot be acquired by a sexual partner, even in the absence of a condom and without the use of preventative measures, including PrEP.24 This is linked to maintaining an undetectable viral load through effective treatment and adherence to ART. Individuals with HIV, following prescribed regimens, have an almost zero risk of transmitting the virus to their sexual partners.9

  • Can a person with undetectable HIV transmit to their children?

    The risk of HIV transmission from the person who gave birth to their child during pregnancy, labour, and delivery is relatively low if the parent’s treatment starts well before delivery and undetectable virus levels are attained.25 Adherence to maternal HIV treatment, with infant HIV medicine for up to six weeks after birth, can reduce mother-to-child transmission to ≤1%.8

    Explore more about HIV in women and HIV in pregnancy to find more information on these topics.

  • Can undetectable HIV be transmitted through blood?

    Current evidence supporting U=U applies only to sexual transmission.1 There is insufficient evidence to conclude that an undetectable viral load completely eliminates the risk of HIV transmission through blood exposures, such as needlestick injuries or sharing injecting equipment.26

    Although evidence is limited, the transmission risk following blood exposure is considered likely to be negligible when the source has sustained viral suppression. However, post-exposure management should still follow current clinical guidelines.27

  • Can undetectable HIV be transmitted through oral sex?

    The risk of transmitting undetectable HIV through oral sexual activities is extremely low, even without an undetectable HIV viral load. No studies have specifically evaluated oral sex transmission when the partner with HIV is on ART with an undetectable viral load, although experts consider transmission in this setting to be effectively impossible.28,29

  • Can you get HIV from someone who is undetectable?

    It depends on the route of transmission. A person with a sustained undetectable viral load will not transmit HIV through sex (U=U).1 For other routes, such as pregnancy, breastfeeding or blood exposure, the risk is low but not always zero and depends on the specific circumstances and current clinical guidance.25–27

  • Studies on HIV transmission in individuals with undetectable HIV

    Several studies — including HPTN 052, PARTNER, PARTNER 2, and Opposites Attract — consistently demonstrate that daily adherence to ART leads to an undetectable viral load level. This resulted in low or zero sexual HIV transmission rates between individuals with undetectable HIV and their HIV-negative partners.19,30–32

    Study
    Details
    Outcome

    HIV Prevention Trials Network (HPTN) 052 (published 2016)30

    1,763 serodifferent heterosexual couples were randomised to immediate or delayed ART. Immediate ART significantly reduced HIV transmission, and condom use was high.

    All linked HIV transmissions occurred when the partner living with HIV had a detectable viral load (17 deferred ART; one early infection before viral suppression in the immediate ART group). Follow-up continued for four years.

    PARTNER (published 2016)31

    Prospective observational study of ~900 European serodifferent couples reporting condomless sex.

    No linked HIV transmissions occurred after more than 58,000 condomless sex acts when the partner with HIV maintained a viral load <200 copies/mL.

    PARTNER2 (published 2019)19

    Extension of the PARTNER study with additional follow-up in gay male serodifferent couples.

    No linked HIV transmissions occurred across >77,000 condomless sex acts in gay male serodifferent couples when the partner with HIV maintained a viral load <200 copies/mL.

    Opposites Attract (published 2018)32

    Prospective observational study of 358 gay male serodifferent couples across Australia, Thailand and Brazil.

    No linked HIV transmissions occurred when the partner with HIV had a viral load <200 copies/mL.

    This scientific evidence underscores the effectiveness of ART in preventing the sexual transmission of HIV when maintaining an undetectable viral load. 

REAL CONVERSATIONS AND REAL STORIES ABOUT U=U

Data from the Positive Perspectives Wave 2 study demonstrates the importance of people with HIV being informed about U=U by their HCPs. Global data from the study showed a wide variability of awareness across different genders and sexual orientations. Men who have sex with men had the highest awareness of U=U, while men who have sex with women had the lowest awareness.

The study also found that patients with HIV who were informed about U=U by an HCP had better mental, physical, sexual, and overall health outcomes compared to those who were not aware of U=U at all:

  • Effective ART can reduce the risk of developing opportunistic infections and other complications due to a weakened immune system associated with HIV.33
  • Confidence in U=U has been associated with lower HIV-related self-stigma, fewer anxiety symptoms, greater sexual satisfaction, and improved feelings about living with HIV.2–4
  • Communicating the U=U message has been associated with increased HIV testing uptake, improved self-image among people living with HIV, and reduced anticipated stigma related to dating and sexual relationships.

This highlights the importance of having meaningful conversations about U=U with your HCP and how they may positively impact health outcomes.5 Ben Young also emphasises the importance of community engagement.

“[W]e must engage with people who distrust science and experts and help them reach a place where U=U is understood, accepted, and passed on. Or in other words, to beat the virus, we need messages that can themselves go viral.”
Ben Young
Head of Global Medical Directors at ViiV Healthcare

The power of U=U against stigma

Understanding the global barriers to treatment, use, and adherence is crucial to making U=U a reality for all people living with HIV. In the words of Ben Young, Head of Global Medical Directors at ViiV Healthcare, U=U is not just a “warm fuzzy concept.” 

“Communicating U=U really has the potential to benefit every step of the HIV care continuum – from testing to engagement in care to viral suppression, and quality of life.”
Ben Young, Head of Global Medical Directors at ViiV Healthcare

HIV stigma stands as an obstacle to treatment and U=U education. Bruce Richman has experienced first-hand the effects of HIV stigma. “When I was diagnosed, I was privileged to have access to quality healthcare, but because of my internalised HIV stigma, I only started treatment seven years later when I was in hospital. While today I’m out and proud about my HIV, back then I took the labels off my bottles and hid the medication in case anyone would discover I was living with HIV.”

He adds that “at least 10 million people around the world have yet to experience the life-changing personal and public health benefits of viral suppression.”

"Understanding the barriers to treatment uptake and adherence for people around the world is vital if we are to finally make U=U a reality for all people living with HIV, which is the way to not only improve their quality of life but to eliminate new transmissions."

BRUCE RICHMAN

Founding Executive Director of Prevention Access Campaign / “Undetectable = Untransmittable” movement

At ViiV Healthcare, we advocate for access to medicines to address these challenges and help contribute towards making U=U possible for everyone. In this episode of Science on the Sofa, our ViiV community member Paulina Tshuma highlights the importance of spreading awareness and coming together as a “whole village,” educating everyone “about U=U globally.”

THE HISTORY OF U=U

The roots of U=U can be traced back to Bruce Richman and the Prevention Access Campaign (PAC), founded in 2016, with the mission of transforming the global understanding of HIV transmission. Bruce Richman has described U=U as a “simple equation (that) has profound implications for everyone living with HIV and for economies and governments around the world.” 'U equals U' campaigns such as the PAC emphasise that achieving and maintaining an undetectable viral load plays a key role in preventing the transmission of HIV.34

FREQUENTLY ASKED QUESTIONS ABOUT U=U

  • How long can HIV be in your system undetected?

    If you mean an undetectable viral load, HIV can remain undetectable for many years as long as HIV treatment is taken as prescribed.35 Regular viral load tests are used to confirm that HIV remains suppressed over time. If treatment is stopped, the viral load usually becomes detectable again within weeks.8,36

    If you mean undiagnosed HIV, a person can have HIV for years without knowing it because symptoms may be mild or absent. The only way to know for sure is to get tested.37

  • Can a person with undetectable HIV donate blood

    Despite having an undetectable viral load, individuals with HIV, including those with undetectable levels, are generally restricted from donating blood due to the potential presence of the virus.38

  • Can an HIV undetectable mother breastfeed?

    For mothers receiving ART who maintain a sustained undetectable viral load throughout pregnancy and while breastfeeding, the risk of HIV transmission through breast milk is estimated to be below 1%, although it is not completely eliminated.39

    Mothers living with HIV who are considering breastfeeding should receive evidence-based, person-centred counselling about infant feeding options.39

  • What is the life expectancy of someone who is living with HIV and undetectable?

    People living with HIV who are undetectable and receive effective treatment can now have life expectancies similar to those of the general population, particularly when treatment is started early and CD4 counts remain high.40

    Age and CD4 cell count remain the strongest predictors of life expectancy, highlighting the importance of early HIV diagnosis and starting treatment before substantial immune damage occurs.40

    Group*

    		 Women

    Men

    General population

    85.8 years

    		 80.7 years

    Started ART after 2015 with a CD4 count ≥500 cells/μL

    		 82.0 years 79.2 years
    Started ART before 2015 + CD4 ≥500 cells/μL 80.2 years 78.0 years

    *Estimates represent total life expectancy for a person aged 40 years and are calculated by adding the study's reported remaining life expectancy at age 40 to the baseline age. General population estimates are derived from the matched comparator population used in the study.40

  • Do you need to disclose your HIV status if you are undetectable?

    While undetectable HIV reduces sexual transmission risk to zero, disclosure remains important for reasons related to law, ethics, and trust in relationships. If you are a healthcare worker, work in the military or in aviation, are applying for health insurance, or are donating blood, it is important to disclose your HIV status. If you are dating someone with HIV, it’s important to know that open communication challenges stigma, educates others, and empowers individuals. However, the decision to disclose is ultimately personal.16

Abbreviations:

ART, antiretroviral therapy; CD4, cluster of differentiation 4; CDC, Centers for Disease Control and Prevention; HCP, healthcare professional; PAC, Prevention Access Campaign; PrEP, pre-exposure prophylaxis; U=U, undetectable equals untransmittable; WHO, World Health Organization.

Exploring the power of U=U for HIV
Being empowered in your care

YOU MAY ALSO BE INTERESTED IN

Deborah Waterhouse, CEO at ViiV Healthcare

HIV Prevention: What to know

HIV prevention methods encompass a range of approaches that are both medical and non-medical. We believe a comprehensive approach, combining both of these alternatives, is key to creating a holistic prevention strategy.

Read more

Black man living with HIV working from his home in his laptop accompanied by his partner

HIV testing and diagnosis insights

Learn all about the diagnosis of HIV, including what HIV testing involves, understanding HIV test results and dealing with an HIV diagnosis.

Read more

NA

Who should take PrEP?

Pre-exposure prophylaxis (PrEP) is prescription medication used by HIV-negative individuals to reduce their chances of acquiring HIV. When taken properly, PrEP is 99% effective at preventing HIV through sex.

Read more

References:

  1. CDC. Undetectable = Untransmittable. Global HIV and TB. 2024. Accessed October 2026. https://www.cdc.gov/global-hiv-tb/php/our-approach/undetectable-untransmittable.html
  2. Rendina HJ, Talan AJ, Cienfuegos-Szalay J, Carter JA, Shalhav O. Treatment is more than prevention: Perceived personal and social benefits of undetectable = Untransmittable messaging among sexual minority men living with HIV. AIDS Patient Care STDS. 2020;34(10):444-451.
  3. Sineke T, Bor J, King R, et al. Integrating “undetectable equals untransmittable” into HIV counselling in South Africa: the development of locally acceptable communication tools using intervention mapping. BMC Public Health. 2024;24(1):1052.
  4. Palich R, Pelchen-Matthews A, Kall M, et al. Belief in the “Undetectable equals Untransmissible”(U=U) statement and associations with stigma, mental health and sexual satisfaction in people living with HIV (PWH) in the UK. AIDS. Published online April 7, 2026:10.1097/QAD.0000000000004517.
  5. Okoli C, Van de Velde N, Richman B, et al. Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries. Sex Transm Infect. 2021;97(1):18-26.
  6. Terrence Higgins Trust (THT). Frequently Asked Questions about U = U. https://tht.org.uk/sites/default/files/2021-11/Frequently%20Asked%20Questions%20about%20UU.pdf
  7. Terrence Higgins Trust (THT). Difficult questions about U=U. Accessed October 2026. https://tht.org.uk/about-us/what-we-do/training/cant-pass-it-training/difficult-questions-about-uu
  8. HIV.gov Viral Suppression and an Undetectable Viral Load. 2026. Accessed October 2026. https://www.hiv.gov/hiv-basics/staying-in-hiv-care/hiv-treatment/viral-suppression
  9. WHO. The role of HIV viral suppression in improving individual health and reducing transmission. 2023. Accessed October 2026. https://www.who.int/publications/i/item/9789240055179
  10. Broyles LN, Luo R, Boeras D, Vojnov L. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. Lancet. 2023;402(10400):464-471.
  11. Byrd KK, Hou JG, Hazen R, et al. Antiretroviral adherence level necessary for HIV viral suppression using real-world data. J Acquir Immune Defic Syndr. 2019;82(3):245-251.
  12. Hussen S, Mama M, Mekonnen B, et al. Adherence level to antiretroviral therapy predict the time to viral load suppression of adult people living with HIV on antiretroviral therapy in Arba Minch general hospital. Chin Med J (Engl). 2019;132(23):2891-2892.
  13. NIAID.NIH. 10 Things to Know About HIV Suppression. 2025. Accessed October 2026. https://www.niaid.nih.gov/diseases-conditions/10-things-know-about-hiv-suppression
  14. Ford OG, Rufurwadzo TG, Richman B, Green I, Alesi J. Adopting U = U to end stigma and discrimination. J Int AIDS Soc. 2022;25(3):e25891.
  15. Torres TS, Luz PM. U = U for all: Advancing equity in HIV prevention. PLoS Med. 2026;23(5):e1005090.
  16. Bessong PO, Matume ND, Tebit DM. Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview. AIDS Res Ther. 2021;18(1):1.
  17. Zuniga JM. U = U: A catalyst for ending AIDS as a public health threat. J Int Assoc Provid AIDS Care. 2024;23:23259582241282561.
  18. Medina-Marino A, Sibanda N, Putt M, et al. Improving HIV testing, linkage, and retention in care among South African men through U=U messaging: A study protocol for two sequential hybrid type 1 effectiveness- implementation randomized controlled trials. Res Sq. Published online October 4, 2023:rs.3.rs - 3349696.
  19. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428-2438.
  20. clinicalinfo.hiv.gov. Virologic Failure and Antiretroviral Options. 2024. Accessed October 2026. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/virologic-failure
  21. Crawshaw J, McCleary N. Healthcare provider interventions to support medication adherence: state-of-the-science overview. Front Pharmacol. 2025;16(1567967):1567967.
  22. CDC. Getting Tested for HIV. February 11, 2025. Accessed October 2026. https://www.cdc.gov/hiv/testing/index.html
  23. Public Health Ontario. HIV-1 RNA Viral Load. Accessed October 2026. https://www.publichealthontario.ca/en/Laboratory-Services/Test-Information-Index/HIV-Viral-Load
  24. i-base. U=U: Undetectable = Untransmittable. 2025. Accessed October 2026. https://i-base.info/u-equals-u/
  25. Eriksen J, Albert J, Axelsson M, et al. Contagiousness in treated HIV-1 infection. Infectious Diseases. Published online October 12, 2020:1-8.
  26. hivguidelines.org. U=U Guidance for Implementation in Clinical Settings. 2023. Accessed October 2026. https://www.hivguidelines.org/guideline/u-equals-u/
  27. Cresswell F, Asanati K, Bhagani S, et al. UK guideline for the use of HIV post-exposure prophylaxis 2021. HIV Med. 2022;23(5):494-545.
  28. HIV.gov. How Is HIV Transmitted? 2026. Accessed October 2026 https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/how-is-hiv-transmitted
  29. Barré-Sinoussi F, Abdool Karim SS, Albert J, et al. Expert consensus statement on the science of HIV in the context of criminal law. J Int AIDS Soc. 2018;21(7):e25161.
  30. Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830-839.
  31. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171.
  32. Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438-e447.
  33. Sadiq U, Shrestha U, Guzman N. Prevention of opportunistic infections in HIV/AIDS. In: StatPearls. StatPearls Publishing; 2025.
  34. Prevention Access Campaign. Accessed October 2026. https://preventionaccess.com/
  35. CDC. Clinical Care of HIV. HIV Nexus: CDC Resources for Clinicians. 2026. Accessed October 2026. https://www.cdc.gov/hivnexus/hcp/clinical-care/index.html
  36. clinicalinfo.hiv.gov. Discontinuation or Interruption of Antiretroviral Therapy. 2022. Accessed October 2026. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/discontinuation-or-interruption-antiretroviral-therapy
  37. HIV.gov. Acute and Chronic HIV. July 1, 2026. Accessed October 2026. https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/acute-and-chronic-hiv
  38. HIV infection: information for blood donors. In: Blood Donor Counselling: Implementation Guidelines. World Health Organization; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK310571/
  39. CDC. HIV and Breastfeeding. Breastfeeding special circumstances. 2025. Accessed October 2026. https://www.cdc.gov/breastfeeding-special-circumstances/hcp/illnesses-conditions/hiv.html
  40. Trickey A, Sabin CA, Burkholder G, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295-e307.

NP-GBL-HVX-COCO-240010 | September 2026

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.